Ironwood Pharmaceuticals, Inc. IRWD reported break-even earnings for the second quarter of 2024 compared with the Zacks Consensus Estimate of earnings of 17 cents per share. The company had recorded ...
Source LinkIronwood Pharmaceuticals, Inc. IRWD reported break-even earnings for the second quarter of 2024 compared with the Zacks Consensus Estimate of earnings of 17 cents per share. The company had recorded ...
Source Link
Comments